Litcius/Paper detail

Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern

Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh T. Nguyen, Yaoxing Huang, Lihong Liu, David D. Ho, Joseph Sodroski

2021iScience22 citationsDOIOpen Access PDF

Abstract

We compared the functional properties of spike (S) glycoproteins from the original SARS-CoV-2 strain (D614) (Wuhan, China), the globally dominant D614G strain, and emerging geographic variants: B.1.1.7 (United Kingdom), B.1.351 (South Africa), P.1 (Brazil), and B.1.1.248 (Brazil/Japan). Compared with D614G, the emerging variants exhibited an increased affinity for the receptor, ACE2, and increased ability to infect cells with low ACE2 levels. All variants lost infectivity similarly at room temperature and 37°C; however, in the cold, B.1.1.7 was more stable, and P.1 and B.1.1.248 were less stable. Shedding of the S1 glycoprotein from the S contributed to virus inactivation in the cold. B.1.351, P.1, and B.1.1.248 were neutralized by convalescent and vaccinee sera less efficiently than the other variants. S glycoprotein properties such as requirements for ACE2 levels on the target cell, functional stability in the cold, and resistance to host neutralizing antibodies potentially contribute to the outgrowth of emerging SARS-CoV-2 variants.

Topics & Concepts

GlycoproteinInfectivityAntibodyVirologyBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorCoronavirus disease 2019 (COVID-19)Strain (injury)VirusNeutralizing antibodyImmunologyGeneticsMedicineDiseaseInternal medicineInfectious disease (medical specialty)AnatomySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies